As a crucial component of YGYZ, Icariin can inhibit LM progression by upregulating p53 and Bax proteins while downregulating Bcl-2, thus promoting apoptosis in CRC cells (Zhang et al., 2019). The gene discussed is BCL2; the disease is colorectal carcinoma.